Bilimsel Makale Arama | NeuralCipher AI

Açık erişim

Impact of type 2 diabetes mellitus on acute levodopa responsiveness in Parkinson's disease: A Multicenter retrospective study.

Stockmann O, Ye L, Buhmann C, Maass F, van Riesen C, Weinrich C, Wegner F, Höllerhage M, Pötter-Nerger M, Klietz M.

Clin Park Relat Disord · 2026-09-15

DOI: 10.1016/j.prdoa.2026.100502PMID: 42824654

Europe PMC üzerinden doğrulanabilir bibliyografik kayıt.

Makale detayına git Kaynağa git ↗

Açık erişim

Rethinking the concept of disease modification in an evolving Parkinson's disease treatment landscape.

Antonini A, Gross RE, De Leon M, Kwok K, Foltynie T, Höglinger G, Gasser T, Corvol JC, Pedrosa DJ, Volkmann J, Henchcliffe C.

J Parkinsons Dis · 2026-09-15

DOI: 10.1177/1877718x261481704PMID: 42742463

Europe PMC üzerinden doğrulanabilir bibliyografik kayıt.

Makale detayına git Kaynağa git ↗

Kaynak kaydı

Depression in Parkinson's Disease: Real-World Prescribing Patterns and Treatment Dynamics from a Nationwide Greek Cohort.

Karageorgiou V, Skapinakis P, Michopoulos I, Mitrou P, Thireos E, Gournellis R.

Mov Disord Clin Pract · 2026-09-15

DOI: 10.1002/mdc3.70809PMID: 42742618

Europe PMC üzerinden doğrulanabilir bibliyografik kayıt.

Makale detayına git Kaynağa git ↗

Kaynak kaydı

Maintenance Electroconvulsive Therapy Emphasizing Relapse Prevention in Parkinsonian Syndromes With Psychiatric Comorbidities.

Sherpa TD, Biswas T, Thakkar V, Mishra A, Mishra BR.

J ECT · 2026-09-15

DOI: 10.1097/yct.0000000000001318PMID: 42743949

Europe PMC üzerinden doğrulanabilir bibliyografik kayıt.

Makale detayına git Kaynağa git ↗

Kaynak kaydı

The mechanism of cerebellar involvement in cognitive disorders and therapeutic prospects.

Chen X, Fu P, Kang C, Wu Y, Wu Y, Luo X, Chen L, Liu H, Ouyang J, Zhang M, Yin X, Chen Z.

Exp Gerontol · 2026-09-15

DOI: 10.1016/j.exger.2026.113324PMID: 42744009

Europe PMC üzerinden doğrulanabilir bibliyografik kayıt.

Makale detayına git Kaynağa git ↗

Açık erişim

Targeting protein aggregate co-pathologies in neurodegeneration: a viable therapeutic strategy?

Buck SA, Madhavan SS, Sanders LH.

Mol Neurodegener Adv · 2026-09-14

DOI: 10.1186/s44477-026-00047-8PMID: 42745993

Europe PMC üzerinden doğrulanabilir bibliyografik kayıt.

Makale detayına git Kaynağa git ↗

Kaynak kaydı

Cu/Cu<sub>2</sub>O-embedded carbon from Cu-MOF integrated with MWCNTs-COOH for sensitive levodopa detection in biological samples.

Ma N, Wei A, Peng H, Xie L, Jin Y, Li G.

Colloids Surf B Biointerfaces · 2026-09-12

DOI: 10.1016/j.colsurfb.2026.116177PMID: 42743869

Europe PMC üzerinden doğrulanabilir bibliyografik kayıt.

Makale detayına git Kaynağa git ↗

Kaynak kaydı

Premorbid depression across levodopa equivalent daily dose-defined treatment trajectories in Parkinson's disease: A nationwide register-based cohort study.

Langeskov-Christensen M, Borghammer P, Østergaard SD, Rohde C.

Parkinsonism Relat Disord · 2026-09-12

DOI: 10.1016/j.parkreldis.2026.108984PMID: 42766893

Europe PMC üzerinden doğrulanabilir bibliyografik kayıt.

Makale detayına git Kaynağa git ↗

Açık erişim

Isolated auditory hallucinations as the initial neuropsychiatric manifestation of dementia with Lewy bodies: diagnostic pathway and individualized therapy (a case report).

Hou L, Ma X, Wang C, Ji L, Peng P.

Front Psychiatry · 2026-09-11

DOI: 10.3389/fpsyt.2026.1935514PMID: 42798501

Europe PMC üzerinden doğrulanabilir bibliyografik kayıt.

Makale detayına git Kaynağa git ↗

Kaynak kaydı

Reversible exacerbation of parkinsonism during epirubicin-cyclophosphamide chemotherapy in a patient with PTEN hamartoma tumor syndrome and young-onset Parkinson's disease.

Wakamatsu N, Norimura S, Nakagawa M, Hirao A, Mukai M, Urai Y, Toda T, Tsuji S, Mitsui J.

Neurol Sci · 2026-09-11

DOI: 10.1007/s10072-026-09361-1PMID: 42726292

Europe PMC üzerinden doğrulanabilir bibliyografik kayıt.

Makale detayına git Kaynağa git ↗

Kaynak kaydı

A novel pipeline for the validation of manganese chelators for the treatment of manganese overload.

Vogt HK, Pojani C, Devonport J, McGown A, Firth G, Doykov I, Nikolaenko V, Anagianni S, Valdivia LE, Khalil Y, Bodnár N, Kállay C, Dadswell C, Gonzalez-Mendez R, Purchase R, Platt FM, Zacconi FCM, Geard AF, Heywood WE, Mills K, Mills PB, Rahim AA, Rihel J, Wilson SW, Kostakis GE, Spencer J, Tuschl K.

Biochem Pharmacol · 2026-09-11

DOI: 10.1016/j.bcp.2026.118465PMID: 42727654

Europe PMC üzerinden doğrulanabilir bibliyografik kayıt.

Makale detayına git Kaynağa git ↗

Kaynak kaydı

Advances in Novel Drug Delivery Systems for Targeting the Brain: Overcoming Barriers and Enhancing Therapeutic Efficacy.

Bhise MR, Thejomoorthy K, Kumar M, Patel PKN, Mahajan V, Naquvi KJ, Ansari I, Kumar A.

Curr Drug Deliv · 2026-09-11

DOI: 10.2174/0115672018474663260907142216PMID: 42764574

Europe PMC üzerinden doğrulanabilir bibliyografik kayıt.

Makale detayına git Kaynağa git ↗

Kayıtlar bilimsel kaynaklardan alınır. Bibliyografik kayıt sayısı, Türkçe çeviri veya editoryal onay sayısı değildir.

20.463 makale bulundu

Impact of type 2 diabetes mellitus on acute levodopa responsiveness in Parkinson's disease: A Multicenter retrospective study.

Rethinking the concept of disease modification in an evolving Parkinson's disease treatment landscape.

Depression in Parkinson's Disease: Real-World Prescribing Patterns and Treatment Dynamics from a Nationwide Greek Cohort.

Maintenance Electroconvulsive Therapy Emphasizing Relapse Prevention in Parkinsonian Syndromes With Psychiatric Comorbidities.

The mechanism of cerebellar involvement in cognitive disorders and therapeutic prospects.

Targeting protein aggregate co-pathologies in neurodegeneration: a viable therapeutic strategy?

Cu/Cu<sub>2</sub>O-embedded carbon from Cu-MOF integrated with MWCNTs-COOH for sensitive levodopa detection in biological samples.

Premorbid depression across levodopa equivalent daily dose-defined treatment trajectories in Parkinson's disease: A nationwide register-based cohort study.

Isolated auditory hallucinations as the initial neuropsychiatric manifestation of dementia with Lewy bodies: diagnostic pathway and individualized therapy (a case report).

Reversible exacerbation of parkinsonism during epirubicin-cyclophosphamide chemotherapy in a patient with PTEN hamartoma tumor syndrome and young-onset Parkinson's disease.

A novel pipeline for the validation of manganese chelators for the treatment of manganese overload.

Advances in Novel Drug Delivery Systems for Targeting the Brain: Overcoming Barriers and Enhancing Therapeutic Efficacy.

Filtreler